Status:
COMPLETED
Effectiveness of TechCR Among CHD Patients
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Coronary Heart Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
During this ongoing pandemic, there is a crucial need for innovative approaches to deliver CR programmes other than frequent face-to-face sessions at the centre-based CR to reduce the number of times ...
Detailed Description
In recent years, CR delivery platforms and approaches have been changing as technology has become an integral part of our daily lives. Some of the barriers to CR may be able to be tackled with the adv...
Eligibility Criteria
Inclusion
- adults ≥ 18 years old;
- patients with documented acute myocardial infarction, treated with thrombolysis, angioplasty or revascularisation surgery;
- patients who own a mobile phone with internet access;
- patients who have at least completion of primary school education;
- understand English or Malay language;
- patients who will return home for living after hospital discharge;
- patients who are medically stable and referred to CR programme and able to give informed consent to participate in this study.
Exclusion
- patients who are participating in other studies;
- patients who will undergo any repeat cardiac or other procedure in next 12 months;
- patients with comorbidities such as dementia, impaired hearing or vision or psychiatric illness which may affect the ability to participate in the CR programme;
- patients with pre-existing mobility problems which prevent them from exercising
Key Trial Info
Start Date :
February 26 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2023
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT04862351
Start Date
February 26 2021
End Date
October 31 2023
Last Update
April 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Malaya Medical Centre
Kuala Lumpur, Kuala Lumpur, Malaysia